Roc vs. Sux - The CURASMUR Trial

February 18, 2020 00:19:11
Roc vs. Sux - The CURASMUR Trial
Critical Care Perspectives in Emergency Medicine
Roc vs. Sux - The CURASMUR Trial

Feb 18 2020 | 00:19:11

/

Show Notes

The debate on the ideal neuromuscular blocking agent for RSI in emergency intubations rages on. In this podcast, we review the latest randomized trial comparing rocuronium with succinylcholine in out-of-hospital patients needing emergency tracheal intubation – The CURASMUR Trial. Emergency medicine airway guru Dr. Ken Butler takes us through the paper and provides his expert opinion on which NMBA you should be reaching for in your next intubation!

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode

January 29, 2019 00:30:02
Episode Cover

Episode 2

[mepr-active rule="1" ifallowed="hide"]Anything in-between gets protected[/mepr-active] hey

Listen

Episode

January 24, 2017 00:45:17
Episode Cover

Top Articles of 2016

It’s time for our annual literature update of the best and most discussed articles from 2016!  Simply a great discussion on important topics such...

Listen

Episode

April 27, 2020 00:22:04
Episode Cover

Vasopressors & The Older Patient - The 65 Trial

Current guidelines for many critical illnesses recommend targeting a MAP of 65 mm Hg, with consideration of higher MAPs in older patients with chronic...

Listen